Jadenu Approval History
Jadenu (deferasirox) is a tablet formulation of Exjade, an iron chelator indicated for the treatment of chronic iron overload due to blood transfusions in patients 2 years of age and older.
Development History and FDA Approval Process for Jadenu
|Mar 30, 2015||FDA Approves Jadenu (deferasirox) Tablets for Chronic Iron Overload|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.